Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.
Open | $137.830 |
Close | $137.920 |
Volume / Avg. | 1.246M / 855.240K |
Day Range | 135.970 - 138.720 |
52 Wk Range | 89.040 - 148.370 |
Market Cap | $13.724B |
P/E Ratio | 55.765 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 2.54% |
Days to Cover | 2.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neurocrine Biosciences (NASDAQ: NBIX) through any online brokerage.
Other companies in Neurocrine Biosciences’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Neurocrine Biosciences (NASDAQ: NBIX) was reported by JP Morgan on Wednesday, March 20, 2024. The analyst firm set a price target for 158.00 expecting NBIX to rise to within 12 months (a possible 14.56% upside). 61 analyst firms have reported ratings in the last year.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $137.92 last updated March 28, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Neurocrine Biosciences.
Neurocrine Biosciences’s Q4 earnings are confirmed for Friday, February 10, 2023.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.